Beximco Pharmaceuticals Limited (BXP.L)
GBp 36.5
(0.0%)
GBp 36.5
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 44.39 Billion | 39.26 Billion | 34.66 Billion | 29.49 Billion | 25.61 Billion | 22.81 Billion |
| Cost of Revenue | 24.75 Billion | 21.95 Billion | 18.85 Billion | 15.57 Billion | 13.71 Billion | 12.19 Billion |
| Gross Profit | 19.63 Billion | 17.31 Billion | 15.81 Billion | 13.92 Billion | 11.89 Billion | 10.62 Billion |
| Operating Expenses | 10.95 Billion | 9.89 Billion | 9.27 Billion | 7.59 Billion | 6.52 Billion | 5.75 Billion |
| Selling, General and Administrative Expenses | 10.95 Billion | 10.21 Billion | 8.91 Billion | 7.27 Billion | 6.28 Billion | 5.55 Billion |
| Research and Development Expenses | - | 363.02 Million | 281.21 Million | 234.68 Million | 180.94 Million | 49.46 Million |
| Other Expenses | - | -677.45 Million | 78 Million | 88.06 Million | 54.86 Million | 151.47 Million |
| Cost and Expenses | 35.71 Billion | 32.05 Billion | 28.12 Billion | 23.16 Billion | 20.23 Billion | 17.95 Billion |
| Operating Income | 8.67 Billion | 7.21 Billion | 6.9 Billion | 6.65 Billion | 5.6 Billion | 5.06 Billion |
| Interest Expense | 1.15 Billion | 1.28 Billion | 1 Billion | 858.68 Million | 1.01 Billion | 1.02 Billion |
| Income Tax Expense | 1.65 Billion | 1.54 Billion | 1.68 Billion | 1.21 Billion | 1.1 Billion | 905.66 Million |
| Earnings before Tax | 7.52 Billion | 6.06 Billion | 6.68 Billion | 6.37 Billion | 4.65 Billion | 3.94 Billion |
| Net Income | 5.82 Billion | 4.61 Billion | 5.12 Billion | 5.12 Billion | 3.51 Billion | 3.03 Billion |
| Earnings Per Share Basic | 13.07 | 10.34 | 11.48 | 11.49 | 7.88 | 6.80 |
| Earnings Per Share Diluted | 13.07 | 10.34 | 11.48 | 11.49 | 7.88 | 6.80 |
| Weighted Average Shares Outstanding | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million | 445.92 Million | 446.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million | 445.92 Million | 446.11 Million |
| Gross Margin | 0.44 | 0.44 | 0.46 | 0.47 | 0.46 | 0.47 |
| EBIT Margin | 0.20 | 0.24 | 0.22 | 0.25 | 0.22 | 0.22 |
| Profit Margin | 0.13 | 0.12 | 0.15 | 0.17 | 0.14 | 0.13 |
| EBITDA | 8.68 Billion | 9.37 Billion | 8.24 Billion | 7.38 Billion | 5.83 Billion | 5.12 Billion |
| Earnings Before Tax Margin | 0.20 | 0.18 | 0.20 | 0.23 | 0.22 | 0.22 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 10.98 Billion | 10.9 Billion | 11.15 Billion | 10.03 Billion | 39.26 Billion | 9.55 Billion |
| Cost of Revenue | 6.18 Billion | 6.01 Billion | 6.27 Billion | 5.79 Billion | 21.95 Billion | 5.34 Billion |
| Gross Profit | 4.8 Billion | 4.89 Billion | 4.88 Billion | 4.23 Billion | 17.31 Billion | 4.21 Billion |
| Operating Expenses | 2.91 Billion | 2.75 Billion | 2.53 Billion | 2.69 Billion | 10.41 Billion | 2.75 Billion |
| Selling, General and Administrative Expenses | 2.82 Billion | 2.65 Billion | 2.67 Billion | 2.63 Billion | - | 2.68 Billion |
| Research and Development Expenses | - | - | - | 363.02 Million | - | - |
| Other Expenses | 114.87 Million | -13.42 Million | - | 90.07 Million | 452.65 Million | 66.37 Million |
| Cost and Expenses | 9.09 Billion | 8.76 Billion | 8.81 Billion | 8.49 Billion | 32.36 Billion | 8.09 Billion |
| Operating Income | 1.97 Billion | 2.23 Billion | 2.2 Billion | 1.6 Billion | 7.21 Billion | 1.53 Billion |
| Interest Expense | 289.03 Million | 273.94 Million | - | 320.43 Million | 1.28 Billion | 320.77 Million |
| Income Tax Expense | 349.24 Million | 408.34 Million | 485.54 Million | 345.7 Million | 1.54 Billion | 319.32 Million |
| Earnings before Tax | 1.71 Billion | 1.84 Billion | 2.05 Billion | 1.3 Billion | 6.06 Billion | 1.22 Billion |
| Net Income | 1.36 Billion | 1.43 Billion | 1.55 Billion | 979.47 Million | 4.61 Billion | 950.56 Million |
| Earnings Per Share Basic | 3.06 | 3.21 | 3.48 | 2.20 | - | 2.13 |
| Earnings Per Share Diluted | 3.06 | 3.21 | 3.48 | 2.20 | - | 2.13 |
| Weighted Average Shares Outstanding | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 446.11 Million | 446.11 Million | 446.11 Million | 446.11 Million | 446.23 Million | 446.11 Million |
| Gross Margin | 0.44 | 0.45 | 0.44 | 0.42 | 0.44 | 0.44 |
| EBIT Margin | 0.18 | 0.19 | 0.24 | 0.16 | - | 0.16 |
| Profit Margin | 0.12 | 0.13 | 0.14 | 0.10 | 0.12 | 0.10 |
| EBITDA | 2 Billion | 2.12 Billion | 2.69 Billion | 1.62 Billion | - | 1.54 Billion |
| Earnings Before Tax Margin | 0.18 | 0.20 | 0.20 | 0.16 | 0.18 | 0.16 |
601116
BPAQF
COSM
2208
FBK
VSSYW